Ready to see if you qualify for GLP-1
The TRANSCEND-CKD trial is investigating whether retatrutides anti-inflammatory and weight-reducing effects translate to preserved kidney function in patients with CKD stage G3
When NNMT activity is elevated as documented in obese adipose tissue, several cancer types, and aged skeletal muscle intracellular NAD+ availability decreases, SAM availability decreases, and downstream sirtuin activity (particularly SIRT1 and SIRT3) is reduced
Post-marketing surveillance is still ongoing What we do know from available research and patient reports: Musculoskeletal side effects (which include muscle cramps) were reported in clinical trials, though at lower rates than gastrointestinal effects Patient forums and post-marketing reports suggest cramping occurs in some patients, particularly during the early weeks of treatment The side effect may be dose-related, with potentially higher incidence at higher doses What patients tend to report about the cramping timeline: Experiences vary widely, but patients in online communities and support groups often describe a pattern where: Cramping tends to first appear within the first 1-2 weeks of starting treatment Many find cramps feel most noticeable around weeks 2-3 A gradual improvement is commonly reported around weeks 4-6 By weeks 8-12, many (though not all) patients report their cramping has significantly improved or resolved Keep in mind that your experience may differ considerably from these general observations
Our vitamin shots are not just quick boosts but targeted therapies designed to help your body perform at its best with ingredients you can trust and results you can feel
The list prices below are not necessarily what you will pay, as the price varies by pharmacy and insurance coverage
